Drug Development Pipeline
AquaADEKs® is an oral antioxidant vitamin formulation specifically for people with CF.
A clinical trial to assess the safety and effectiveness of AquADEKS was completed in 2008. The study showed that vitamin levels significantly increased and signs of inflammation were reduced.
A phase 2 study of AquADEKs in people with CF ages 10 and older was completed in 2015.
The program was sponsored by Yasoo Health, Inc and partially funded by the Cystic Fibrosis Foundation. It was conducted within the Therapeutics Development Network.
A reformulation and additional clinical trials are ongoing.
Recent AquADEKs Studies
Sign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.Learn More